SOADOR
NKTR icon

State of Alaska Department of Revenue’s Nektar Therapeutics NKTR Stock Holding History

State of Alaska Department of Revenue’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,581
Closed -$90K – 1638
2023
Q1 		$90K Sell
8,581
-144
-2% -$4.36K ﹤0.01% 1625
2022
Q4 		$295K Buy
8,725
+75
+0.9% +$3.63K ﹤0.01% 1544
2022
Q3 		$415K Sell
8,650
-744
-8% -$44.3K 0.01% 1399
2022
Q2 		$535K Buy
9,394
+835
+10% +$52.7K 0.01% 1328
2022
Q1 		$691K Sell
8,559
-152
-2% -$22.5K 0.01% 1233
2021
Q4 		$1.76M Buy
8,711
+6,793
+354% +$1.47M 0.02% 775
2021
Q3 		$516K Buy
1,918
+42
+2% +$10.1K 0.01% 1447
2021
Q2 		$482K Sell
1,876
-24
-1% -$6.64K ﹤0.01% 1462
2021
Q1 		$570K Sell
1,900
-40
-2% -$12.4K 0.01% 1362
2020
Q4 		$494K Sell
1,940
-95
-5% -$24.5K 0.01% 1362
2020
Q3 		$506K Sell
2,035
-77
-4% -$24.2K 0.01% 1234
2020
Q2 		$733K Buy
2,112
+94
+5% +$29.3K 0.01% 1052
2020
Q1 		$540K Buy
2,018
+90
+5% +$27.8K 0.01% 1067
2019
Q4 		$624K Sell
1,928
-151
-7% -$43.8K 0.01% 1198
2019
Q3 		$567K Sell
2,079
-683
-25% -$250K 0.01% 1206
2019
Q2 		$1.47M Sell
2,762
-579
-17% -$290K 0.02% 612
2019
Q1 		$1.68M Buy
3,341
+116
+4% +$68.7K 0.03% 559
2018
Q4 		$1.59M Buy
3,225
+182
+6% +$110K 0.03% 544
2018
Q3 		$2.78M Buy
3,043
+179
+6% +$153K 0.05% 446
2018
Q2 		$2.1M Buy
2,864
+2,409
+529% +$2.78M 0.04% 523
2018
Q1 		$724K Sell
455
-1,637
-78% -$2.11M 0.02% 772
2017
Q4 		$1.87M Buy
2,092
+26
+1% +$15.4K 0.04% 489
2017
Q3 		$743K Buy
2,066
+24
+1% +$7.51K 0.04% 570
2017
Q2 		$598K Buy
2,042
+905
+80% +$262K 0.04% 347
2017
Q1 		$400K Buy
1,137
+31
+3% +$6.97K 0.03% 417
2016
Q4 		$203K Buy
+1,106
New +$225K 0.02% 431

Other funds holding NKTR

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

State of Alaska Department of Revenue's NKTR Position: Q2 2023 in Review

State of Alaska Department of Revenue sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 8,581 shares — an estimated $90K sold.

State of Alaska Department of Revenue first reported a position in NKTR in Q4 2016 and held it in 26 quarters. The position peaked at $2.78M in Q3 2018. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.

  • State of Alaska Department of Revenue reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
  • State of Alaska Department of Revenue sold 8,581 Nektar Therapeutics shares in Q2 2023, an estimated $90K.
  • State of Alaska Department of Revenue first reported a position in Nektar Therapeutics in Q4 2016 and held it in 26 quarters.
  • State of Alaska Department of Revenue's Nektar Therapeutics position peaked at $2.78M in Q3 2018.
  • 146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2023, filed 25 Jul 2023.